• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

Alkermes prepares for uncertain launch as FDA finally clears schizophrenia drug





Similar threads

Replies
1
Views
746
Replies
8
Views
4K
Replies
14
Views
3K